- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02896010
Personalized Smartphone-assisted Coaching System to Improve Glucose Homeostasis in Adults With Prediabetes
March 26, 2018 updated by: Johns Hopkins University
Effectiveness of a Personalized Smartphone-assisted Coaching System to Improve Glucose Homeostasis in Adults With Prediabetes: Rationale and Study Protocol - Pilot Study
Sweetch is a personalized mobile-health platform coaching system (mobile phone app) designed to promote adherence to physical activity guidelines for people with prediabetes.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The mobile phone app Sweetch seeks to increase leisure time physical activity rather than formal exercise through the use of a behavioral analytics engine that continuously process various aspects of the user's life habits, taking into account the user's demographics, behavioral change status, schedule, actual activity patterns, and more.
The rationale behind this approach is that long-term adherence and patient engagement are more likely to be achieved when demands on manual user data entry are kept at a minimum.
Compared to similar smartphone-assisted prevention apps, there are two novel features of the Sweetch app that may increase its efficacy.
First, it uses a "just-in-time" adaptive intervention" approach that tailors recommendations to the user's day-to-day routine and his or her readiness for behavioral change.
Second, and most importantly, it requires no direct involvement by the user, since all the necessary data is collected using built-in tracking pedometers, accelerometer and GPS (Global Positioning System) sensors on smartphones.
In contrast, interventions that focus on dietary changes (i.e.
calorie reduction, change in macronutrient content), require active user tracking at every meal, which is difficult to maintain in the long-term even with the use of sophisticated, electronic calorie counting tools.
For these reasons, the Sweetch app may achieve greater long-term adherence, which is usually a limiting factor to efficacy of mobile health interventions.
Study Type
Interventional
Enrollment (Actual)
55
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21287
- Johns Hopkins Hospital
-
-
Pennsylvania
-
Reading, Pennsylvania, United States, 19607
- Reading Health System
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adults aged 18 -75 years with prediabetes (fasting BG 100-125 mg/dl, A1C 5.7% - 6.4%, or 2 hour BG of 140-199 mg/dl following 75-gram oral glucose tolerance test)
- Body mass index 24 - 40 kg/m2
- English speaker
- Smartphone user (Android or Apple 5s and above)
Exclusion Criteria:
- Currently doing more than 150 minutes/week of moderate/vigorous physical activity
- Presence of medical conditions that prevent adoption of moderate physical activity
- Use of any glucose-lowering or weight loss medications within the previous 3 months
- Current pregnancy (self-reported) or planning pregnancy during study period (self-reported)
- Presence of any condition that can result in spurious A1C readings (e.g. anemia [hemoglobin level below lower limit of normal] secondary to iron, vitamin B12, or folate deficiencies; hemoglobinopathies)
- Use of systemic glucocorticoids
- Use of antipsychotic medications (stable doses for at least three months of anti-depressants or anti-anxiety drugs will be allowed)
- Severe mental illness or learning disability
- Current participation in another clinical trial
- Liver enzymes >3 x upper limit of normal
- Poor literacy (REALM-R score of 6 or less)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Sweetch App + DBWS
Participants receive usual care for prediabetes management.
In addition, participants will be randomized to receive the Sweetch app plus weight monitoring via digital body weight scale (DBWS).
|
Usual care for prediabetes management, Sweetch app, weight monitoring via digital body weight scale (DBWS).
|
Active Comparator: Sweetch App Alone
Participants receive usual care for prediabetes management.
In addition, participants will be randomized to receive the Sweetch app alone.
|
Usual care for prediabetes management, Sweetch app alone.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Yield of Recruitment
Time Frame: 3 months
|
Proportion of recruited participants who enroll and complete the 3 month study
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Engagement
Time Frame: 3 months
|
Proportion of enrolled participants who keep app installed and open in background of their smartphones during duration of the study.
|
3 months
|
Usability and Satisfaction
Time Frame: 3 months
|
Usability and Satisfaction will be measured using an adapted Systems Usability Scale, a validated method of measuring usability with a wide array of technological products, including smartphones.
|
3 months
|
Adherence to physical activity goal
Time Frame: 3 months
|
Proportion of enrolled participants meeting mean 150 minute per week physical activity target (evaluated at 4 week intervals and over course of entire 12 week study period)
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Adrian S Dobs, MD MHS, Johns Hopkins University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 10, 2016
Primary Completion (Actual)
November 17, 2017
Study Completion (Actual)
November 17, 2017
Study Registration Dates
First Submitted
August 1, 2016
First Submitted That Met QC Criteria
September 6, 2016
First Posted (Estimate)
September 12, 2016
Study Record Updates
Last Update Posted (Actual)
March 27, 2018
Last Update Submitted That Met QC Criteria
March 26, 2018
Last Verified
March 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00099812
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hyperglycemia
-
Mayo ClinicCompletedHospital Hyperglycemia | Post-transplant HyperglycemiaUnited States
-
Zealand University HospitalNot yet recruitingStress Hyperglycemia | Postoperative Hyperglycemia
-
University of CopenhagenUnknownSurgery--Complications | Hyperglycemia Stress | Hyperglycemia Steroid-inducedDenmark
-
University of LeedsCompletedEffect of Food on Postprandial HyperglycemiaUnited Kingdom
-
Emory UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...RecruitingHyperglycemia StressUnited States
-
Loughborough UniversityUniversity of BedfordshireCompletedPostprandial HyperglycemiaUnited Kingdom
-
Centre Hospitalier Universitaire de BesanconEli Lilly and Company; AstraZenecaCompleted
-
Medical University of ViennaCompleted
-
Addis Ababa UniversityCompletedHyperglycemia, Postprandial
-
University of Eastern FinlandFinnsugar LtdCompletedHyperglycemia, PostprandialFinland
Clinical Trials on Sweetch App Alone
-
Johns Hopkins UniversitySweetch Health, LtdWithdrawnHyperglycemia | Impaired Glucose Tolerance | Prediabetes | Postprandial Hyperglycemia | Impaired Fasting GlucoseUnited States
-
University of BirminghamDairy Management Inc.Completed
-
University of VictoriaRecruiting
-
Hypnalgesics, LLCTufts UniversityCompletedDental Anxiety | Opioid Use | Drug Use | Dental PainUnited States
-
Dennis Turner, M.D.National Institute of Neurological Disorders and Stroke (NINDS); Duke University and other collaboratorsActive, not recruiting
-
McMaster UniversityCompleted
-
Barbara Ann Karmanos Cancer InstituteCompletedCancer | Financial Toxicity | Question Prompt ListUnited States
-
University of California, San FranciscoConquer Cancer FoundationActive, not recruitingProstate Cancer | Metastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
Chang Gung UniversityChang Gung Memorial HospitalRecruiting
-
University of Sao PauloNot yet recruitingPostpartum Depression